BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 33588359)

  • 1. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Mao G; Gigliotti MJ; Esplin N; Sexton K
    Clin Neurol Neurosurg; 2021 Mar; 202():106546. PubMed ID: 33588359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial injection of verapamil in treatment of cerebral vasospasm in a patient with acute subarachnoid hemorrhage from an aneurysm: case report.
    Mikeladze KG; Éliava ShSh; Shekhtman OD; Lubnin AIu; Tabasaranskiĭ TF; Iakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(4):57-60; discussion 60. PubMed ID: 24364247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of single versus multiple vasodilator agents in the treatment of cerebral vasospasm: is more better than less?
    Chen PR; Bulsara K; Lopez-Rivera V; Sheriff FG; Sanzgiri A; Sheth S; Oni-Orisan AO; Vahidy FS; Erkmen K; Kim DH; Day AL
    Acta Neurochir (Wien); 2021 Jan; 163(1):161-168. PubMed ID: 32533411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intra-arterial administration of verapamil for prevention and treatment of cerebral angiospasm after SAH due to cerebral aneurysm rupture].
    Mikeladze KG; Okishev DN; Belousova OB; Konovalov AN; Pilipenko YV; Kheireddin AS; Ageev IS; Shekhtman OD; Kurdyumova NV; Tabasaranskiy TF; Okisheva EA; Eliava SS; Yakovlev SB
    Zh Vopr Neirokhir Im N N Burdenko; 2018; 82(4):23-31. PubMed ID: 30137035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Keuskamp J; Murali R; Chao KH
    J Neurosurg; 2008 Mar; 108(3):458-63. PubMed ID: 18312091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia.
    Abulhasan YB; Ortiz Jimenez J; Teitelbaum J; Simoneau G; Angle MR
    J Neurosurg; 2020 Mar; 134(3):971-982. PubMed ID: 32217799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage.
    Aldrich EF; Higashida R; Hmissi A; Le EJ; Macdonald RL; Marr A; Mayer SA; Roux S; Bruder N
    J Neurosurg; 2020 May; 134(5):1553-1561. PubMed ID: 32442971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The REACT study: design of a randomized phase 3 trial to assess the efficacy and safety of clazosentan for preventing deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Bruder N; Higashida R; Santin-Janin H; Dubois C; Aldrich EF; Marr A; Roux S; Mayer SA
    BMC Neurol; 2022 Dec; 22(1):492. PubMed ID: 36539711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-arterial verapamil-induced seizures: case report and review of the literature.
    Westhout FD; Nwagwu CI
    Surg Neurol; 2007 May; 67(5):483-6; discussion 486. PubMed ID: 17445610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.
    Parra A; Kreiter KT; Williams S; Sciacca R; Mack WJ; Naidech AM; Commichau CS; Fitzsimmons BF; Janjua N; Mayer SA; Connolly ES
    Neurosurgery; 2005 Mar; 56(3):476-84; discussion 476-84. PubMed ID: 15730572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I proof-of-concept and safety trial of sildenafil to treat cerebral vasospasm following subarachnoid hemorrhage.
    Washington CW; Derdeyn CP; Dhar R; Arias EJ; Chicoine MR; Cross DT; Dacey RG; Han BH; Moran CJ; Rich KM; Vellimana AK; Zipfel GJ
    J Neurosurg; 2016 Feb; 124(2):318-27. PubMed ID: 26314998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological changes of intracranial pressure quantifies vasodilatory effect of verapamil to treat cerebral vasospasm.
    Liu X; Vitt JR; Hetts SW; Gudelunas K; Ho N; Ko N; Hu X
    J Neurointerv Surg; 2020 Aug; 12(8):802-808. PubMed ID: 31959633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral vasospasm patterns following aneurysmal subarachnoid hemorrhage: an angiographic study comparing coils with clips.
    Jones J; Sayre J; Chang R; Tian J; Szeder V; Gonzalez N; Jahan R; Vinuela F; Duckwiler G; Tateshima S
    J Neurointerv Surg; 2015 Nov; 7(11):803-7. PubMed ID: 25230840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism.
    Stuart RM; Helbok R; Kurtz P; Schmidt M; Fernandez L; Lee K; Badjatia N; Mayer SA; Lavine S; Meyers P; Connolly ES; Claassen J
    Neurosurgery; 2011 Feb; 68(2):337-45; discussion 345. PubMed ID: 21135735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric Oxide-Based Treatment of Poor-Grade Patients After Severe Aneurysmal Subarachnoid Hemorrhage.
    Ehlert A; Starekova J; Manthei G; Ehlert-Gamm A; Flack J; Gessert M; Gerss J; Hesselmann V
    Neurocrit Care; 2020 Jun; 32(3):742-754. PubMed ID: 31418143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Jun P; Ko NU; English JD; Dowd CF; Halbach VV; Higashida RT; Lawton MT; Hetts SW
    AJNR Am J Neuroradiol; 2010 Nov; 31(10):1911-6. PubMed ID: 20616179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between endothelin polymorphisms and aneurysmal subarachnoid hemorrhage, clinical vasospasm, delayed cerebral ischemia, and functional outcome.
    Griessenauer CJ; Starke RM; Foreman PM; Hendrix P; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Lin M; Walters BC; Pittet JF; Mathru M
    J Neurosurg; 2018 May; 128(5):1311-1317. PubMed ID: 28548598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracisternal administration of verapamil for the prevention and treatment of vasospasm in patients after microsurgical treatment of cerebral aneurysms in the acute period of hemorrhage].
    Pilipenko YV; Varyukhina MD; Eliava SS; Belousova OB; Savin IA; Okishev DN; Mikeladze KG; Shekhtman OD; Kheyreddin AS; Konovalov AN; Gorozhanin VA; Spiru AM; Kurdyumova NV; Tabasaransky TF; Baranich AI; Vinogradov EV
    Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(4):18-33. PubMed ID: 31577267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.